{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:42:46Z","timestamp":1792089766245,"version":"4.4.0"},"reference-count":74,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/na","name":"Italian Ministry of Health-Ricerca Corrente, Italy","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) is characterized by molecular heterogeneity, with BRAF-mutated tumors being particularly aggressive and refractory to standard therapies. This study aimed to identify distinctive proteomic signatures associated with the BRAF V600E mutation through comparative tumor tissue profiling. Thirty-three tumor tissues were analyzed: 9 BRAF-mutated, 14 RAS-mutated, and 10 wild-type (WT). Proteomic profiling was performed on formalin-fixed, paraffin-embedded (FFPE) tissues using bottom-up LC\u2013MS\/MS in a data-independent acquisition mode. Protein identification and relative expression were achieved by using DIA-NN label-free analysis. Group differences were evaluated through multiparametric analyses, and Cox proportional hazard models were applied to identify proteins associated with overall survival. BRAF-mutated tumors showed distinct proteomic alterations, including overexpression of dipeptidyl peptidase 4 (DPP4) and lysophosphatidylcholine acyltransferase 1 (LPCAT1) alongside the downregulation of quinolinic phosphoribosyltransferase (QPRT) involved in NAD+ biosynthesis. Pathway analysis revealed the enrichment of protein folding associated with endoplasmic reticulum (ER) stress. Prognostic accuracy improved when tumor genotype was combined with the expression of activator of HSP90 ATPase activity 1 (AHSA1) and thioredoxin domain-containing 5 (TXNDC5), involved in ER-associated protein folding. These findings define a distinctive proteomic signature in BRAF-mutated CRC, characterized by dysregulated protein folding associated with ER stress and supporting the development of targeted therapies and more precise prognostic models.<\/jats:p>","DOI":"10.1021\/acs.jproteome.6c00178","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:36:18Z","timestamp":1782714978000},"page":"4132-4144","source":"Crossref","is-referenced-by-count":1,"title":["Tissue Proteomic\nSignatures of\n                    <i>BRAF<\/i>\n                    -Mutated Colorectal Cancer Reveal\nNew Insights into Aggressiveness,\nImmune Modulation, and Metabolic Reprogramming"],"prefix":"10.1021","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-295X","authenticated-orcid":true,"given":"Gianmaria","family":"Miolo","sequence":"first","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS , , ,","place":["Aviano (PN), Italy, 33081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally","family":"Marus","sequence":"additional","affiliation":[{"name":"Pordenone Hospital , , ,","place":["Pordenone, Italy, 33170"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-4980","authenticated-orcid":true,"given":"Giovanni","family":"Canil","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS , , ,","place":["Aviano (PN), Italy, 33081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Inversi","sequence":"additional","affiliation":[{"name":"Pordenone Hospital , , ,","place":["Pordenone, Italy, 33170"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS , , ,","place":["Aviano (PN), Italy, 33081"]},{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS , , ,","place":["Aviano (PN), Italy, 33081"]},{"name":"University of Udine , , ,","place":["Udine, Italy, 33100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Corona","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS , , ,","place":["Aviano (PN), Italy, 33081"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"16","key":"2026080709091203700_cit1","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/Cancers15164020","article-title":"Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal\nEvolution, and Clinical Implications","volume":"15","author":"Saoudi Gonza\u0301lez","year":"2023","journal-title":"Cancers\n(Basel)"},{"issue":"10207","key":"2026080709091203700_cit2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal\nCancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"2026080709091203700_cit3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41698-023-00488-4","article-title":"Profiling the Heterogeneity\nof Colorectal Cancer Consensus Molecular Subtypes Using Spatial Transcriptomics","volume":"8","author":"Valdeolivas","year":"2024","journal-title":"Npj Precis. Onc."},{"issue":"7","key":"2026080709091203700_cit4","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1764","article-title":"A Comprehensive\nOverview of the Molecular Features and Therapeutic Targets in BRAFV600E-Mutant Colorectal Cancer","volume":"14","author":"Gu","year":"2024","journal-title":"Clin.\nTransl. Med."},{"issue":"17","key":"2026080709091203700_cit5","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, Binimetinib,\nand Cetuximab in BRAF V600E\u2013Mutated Colorectal","volume":"381","author":"Kopetz","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"2026080709091203700_cit6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa2212419","article-title":"Adagrasib with or without Cetuximab in Colorectal Cancer\nwith Mutated KRAS G12C","volume":"388","author":"Yaeger","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"2026080709091203700_cit7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","article-title":"Sotorasib\nplus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS\nG12C","volume":"389","author":"Fakih","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"2026080709091203700_cit8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/Genes11111342","article-title":"Emerging BRAF\nMutations in Cancer Progression and Their Possible Effects on Transcriptional\nNetworks","volume":"11","author":"S\u0301miech","year":"2020","journal-title":"Genes (Basel)"},{"key":"2026080709091203700_cit9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of Cancer Therapy: Oncogene\nand Non-Oncogene Addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"issue":"11","key":"2026080709091203700_cit10","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.3390\/Cancers12113236","article-title":"BRAF Mutation\nin Colorectal Cancers:\nFrom Prognostic Marker to Targetable Mutation","volume":"12","author":"Nakayama","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2026080709091203700_cit11","doi-asserted-by":"publisher","first-page":"100603","DOI":"10.1016\/j.Esmoop.2022.100603","article-title":"Real-World First-Line\nTreatment of Patients with BRAFV600E-Mutant Metastatic Colorectal\nCancer: The CAPSTAN CRC Study","volume":"7","author":"Martinelli","year":"2022","journal-title":"ESMO Open"},{"issue":"24","key":"2026080709091203700_cit12","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/Cancers15245748","article-title":"The Impact of BRAF\nMutation Status on Survival Outcomes and Treatment Patterns among\nMetastatic Colorectal Cancer Patients in Alberta, Canada","volume":"15","author":"Sutherland","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026080709091203700_cit13a","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.3390\/ijms26083757","article-title":"BRAF Targeting\nAcross Solid Tumors:\nMolecular Aspects and Clinical Applications","volume":"26","author":"Mechahougui","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"2026080709091203700_cit13b","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","article-title":"BRAF Mutant Colorectal Cancer: Prognosis,\nTreatment, and New Perspectives","volume":"28","author":"Sanz-Garcia","year":"2017","journal-title":"Ann. Oncol."},{"key":"2026080709091203700_cit14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib\nin BRAF-Mutated Metastatic Melanoma:\nA Multicentre, Open-Label, Phase 3 Randomised Controlled Trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"2026080709091203700_cit15","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-14-0776","article-title":"FDA Approval\nSummary: Vemurafenib for Treatment of\nUnresectable or Metastatic Melanoma with the BRAFV600E Mutation","volume":"20","author":"Kim","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"2026080709091203700_cit16","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","article-title":"BRAF Mutant Colorectal Cancer: Prognosis, Treatment, and New Perspectives","volume":"28","author":"Sanz-Garcia","year":"2017","journal-title":"Ann. Oncol."},{"issue":"24","key":"2026080709091203700_cit17","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2501912","article-title":"BREAKWATER Trial Investigators. Encorafenib,\nCetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer","volume":"392","author":"Elez","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"2026080709091203700_cit18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/cas.15731","article-title":"Frontiers in Mass Spectrometry\u2013Based\nClinical Proteomics for Cancer Diagnosis and Treatment","volume":"114","author":"Haga","year":"2023","journal-title":"Cancer Sci."},{"issue":"7","key":"2026080709091203700_cit19","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1021\/Pr100234w","article-title":"Proteome,\nPhosphoproteome, and N-Glycoproteome Are Quantitatively Preserved\nin Formalin-Fixed Paraffin-Embedded Tissue and Analyzable by High-Resolution\nMass Spectrometry","volume":"9","author":"Ostasiewicz","year":"2010","journal-title":"J. Proteome Res."},{"issue":"3\u20134","key":"2026080709091203700_cit20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/Prca.201200046","article-title":"Proteomic Workflow for Analysis of\nArchival Formalin-Fixed and Paraffin-Embedded Clinical Samples to\na Depth of 10 000 Proteins","volume":"7","author":"Wis\u0301niewski","year":"2013","journal-title":"Proteomics Clin\nAppl."},{"issue":"1","key":"2026080709091203700_cit21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1074\/Mcp.TIR119.001616","article-title":"Sample Preparation\nby Easy Extraction and Digestion (SPEED) - A Universal, Rapid, and\nDetergent-Free Protocol for Proteomics Based on Acid Extraction","volume":"19","author":"Doellinger","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"2026080709091203700_cit22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/S41592-019-0638-x","article-title":"DIA-NN: Neural\nNetworks and Interference Correction Enable Deep Proteome Coverage\nin High Throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"issue":"1","key":"2026080709091203700_cit23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/cells9010219","article-title":"KRAS and BRAF\nMutations as Prognostic and Predictive\nBiomarkers for Standard Chemotherapy Response in Metastatic Colorectal\nCancer: A Single Institutional Study","volume":"9","author":"Garcia-Carbonero","year":"2020","journal-title":"Cells"},{"issue":"2","key":"2026080709091203700_cit24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/DCR.0b013e31823c08b3","article-title":"BRAF Mutations in\nColorectal Cancer Are Associated With Distinct Clinical Characteristics\nand Worse Prognosis","volume":"55","author":"Kalady","year":"2012","journal-title":"Dis. Colon Rectum"},{"issue":"6","key":"2026080709091203700_cit25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/Er.2014-1035","article-title":"Pharmacology, Physiology,\nand Mechanisms of Action\nof Dipeptidyl Peptidase-4 Inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr.\nRev."},{"issue":"14","key":"2026080709091203700_cit26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2174\/13816128113199990474","article-title":"Dipeptidyl-Peptidase 4 Inhibition:\nLinking Metabolic Control to Cardiovascular Protection","volume":"20","author":"Avogaro","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"2026080709091203700_cit27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cei.12757","article-title":"Unravelling\nthe Immunological Roles of Dipeptidyl Peptidase 4 (DPP4) Activity\nand\/or Structure Homologue (DASH) Proteins","volume":"184","author":"Wagner","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"2026080709091203700_cit28","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2741\/2787","article-title":"The Role\nof CD26\/Dipeptidyl Peptidase IV in Cancer","volume":"13","author":"Havre","year":"2008","journal-title":"Front\nBiosci"},{"issue":"8","key":"2026080709091203700_cit29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/Ni.3201","article-title":"Dipeptidylpeptidase 4 Inhibition\nEnhances Lymphocyte Trafficking, Improving Both Naturally Occurring\nTumor Immunity and Immunotherapy","volume":"16","author":"Barreira Da Silva","year":"2015","journal-title":"Nat. Immunol."},{"issue":"3","key":"2026080709091203700_cit30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10555-019-09807-3","article-title":"Proteolytic Chemokine\nCleavage as a Regulator of Lymphocytic Infiltration in Solid Tumors","volume":"38","author":"Bronger","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"2026080709091203700_cit31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cytogfr.2023.10.003","article-title":"An Emerging\nParadigm of CXCL12 Involvement in the Metastatic Cascade","volume":"75","author":"Anastasiadou","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"17","key":"2026080709091203700_cit32","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.3390\/cancers13174247","article-title":"The Role of Post-Translational\nModifications of Chemokines by CD26 in Cancer","volume":"13","author":"De Zutter","year":"2021","journal-title":"Cancers"},{"issue":"15","key":"2026080709091203700_cit33","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.3390\/ijms26157620","article-title":"Anti-CD26 Antibody\nSuppresses Epithelial-Mesenchymal Transition in Colorectal Cancer\nStem Cells","volume":"26","author":"Iwasawa","year":"2025","journal-title":"IJMS"},{"issue":"9","key":"2026080709091203700_cit34","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-05-1245","article-title":"The Protease Complex Consisting of Dipeptidyl Peptidase\nIV and Seprase Plays a Role in the Migration and Invasion of Human\nEndothelial Cells in Collagenous Matrices","volume":"66","author":"Ghersi","year":"2006","journal-title":"Cancer\nRes."},{"issue":"1","key":"2026080709091203700_cit35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41467-023-35793-w","article-title":"CD26-Negative and CD26-Positive Tissue-Resident\nFibroblasts Contribute to Functionally Distinct CAF Subpopulations\nin Breast Cancer","volume":"14","author":"Houthuijzen","year":"2023","journal-title":"Nat. Commun."},{"key":"2026080709091203700_cit36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/annrheumdis-2016-eular.3133","article-title":"OP0051 Dipeptidyl-Peptidase-4\n(DPP4) Characterizes A Subpopulation of Fibrosis-Promoting Fibroblasts\nand Is A Molecular Target for The Treatment of Fibrosis","volume":"75","author":"Soare","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"22","key":"2026080709091203700_cit37","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1111\/bph.15967","article-title":"Targeting\nCluster of Differentiation\n26\/Dipeptidyl Peptidase 4 (CD26\/DPP4) in Organ Fibrosis","volume":"180","author":"Ohm","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"2026080709091203700_cit38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098582","article-title":"Prognostic Significance of CD26 in\nPatients with Colorectal Cancer","volume":"9","author":"Lam","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2026080709091203700_cit39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/iub.2454","article-title":"The Mechanism\nof Sitagliptin Inhibition of Colorectal Cancer Cell Lines\u2019\nMetastatic Functionalities","volume":"73","author":"Varela-Calvin\u0303o","year":"2021","journal-title":"IUBMB Life"},{"issue":"8","key":"2026080709091203700_cit40","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/jc.2017-00346","article-title":"Dipeptidyl Peptidase\nIV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid\nCarcinoma","volume":"102","author":"Lee","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2026080709091203700_cit41","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/cancers12061571","article-title":"BRAF Mutated Colorectal\nCancer: New Treatment Approaches","volume":"12","author":"Molina-Cerrillo","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"2026080709091203700_cit42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.15252\/emmm.201506145","article-title":"Inhibition of DPP 4 Activity in Humans\nEstablishes Its in Vivo Role in CXCL 10 Post-translational\nModification: Prospective Placebo-controlled Clinical Studies","volume":"8","author":"Decalf","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"2026080709091203700_cit43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/cancers13030487","article-title":"DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment\nand Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model","volume":"13","author":"Wilson","year":"2021","journal-title":"Cancers"},{"issue":"14","key":"2026080709091203700_cit44","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.3390\/Cancers13143588","article-title":"Repurposing DPP-4\nInhibitors for Colorectal Cancer:\nA Retrospective and Single Center Study","volume":"13","author":"Ng","year":"2021","journal-title":"Cancers\n(Basel)"},{"issue":"1","key":"2026080709091203700_cit45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/Mco.2018.1766","article-title":"A Multi-Center Retrospective\nAnalysis of the Effect\nof DPP4 Inhibitors on Progression-Free Survival in Advanced Airway\nand Colorectal Cancers","volume":"10","author":"Ali","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"2026080709091203700_cit46","doi-asserted-by":"publisher","first-page":"840142","DOI":"10.3389\/Fonc.2022.840142","article-title":"Association Between\nDPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients\nWith Diabetes Receiving Second-Line Agents: A Nested Case-Control\nStudy","volume":"12","author":"Chou","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"2026080709091203700_cit47","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/cam4.2278","article-title":"Dipeptidyl Peptidase 4 Inhibitors\nas Novel Agents in Improving Survival in Diabetic Patients with Colorectal\nCancer and Lung Cancer: A Surveillance Epidemiology and Endpoint Research\nMedicare Study","volume":"8","author":"Bishnoi","year":"2019","journal-title":"Cancer Med."},{"issue":"10","key":"2026080709091203700_cit48","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/ijc.28260","article-title":"Long-term Treatment with Sitagliptin, a Dipeptidyl\nPeptidase-4 Inhibitor, Reduces Colon Carcinogenesis and Reactive Oxygen\nSpecies in 1,2-dimethylhydrazine-induced Rats","volume":"133","author":"Femia","year":"2013","journal-title":"Intl Journal of Cancer"},{"key":"2026080709091203700_cit49","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/16015.6979","volume-title":"Evaluation of Anti\nCancer Effects of D PP \u22124 Inhibitors in Colon Cancer- an Invitro\nStudy","author":"Amritha","year":"2015"},{"key":"2026080709091203700_cit50","doi-asserted-by":"publisher","first-page":"705060","DOI":"10.3389\/fcell.2021.705060","article-title":"BRAF Mutation as a Potential Therapeutic\nTarget for Checkpoint Inhibitors: A Comprehensive Analysis of Immune\nMicroenvironment in BRAF Mutated Colon Cancer","volume":"9","author":"Cen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"2026080709091203700_cit51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41416-023-02483-9","article-title":"Opposing Roles by KRAS and BRAF Mutation\non Immune Cell Infiltration in Colorectal Cancer \u2013 Possible\nImplications for Immunotherapy","volume":"130","author":"Edin","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"11","key":"2026080709091203700_cit52","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/cancers14112793","article-title":"The Kynurenine Pathway\nand Cancer: Why Keep It Simple When You Can Make It Complicated","volume":"14","author":"Gouasmi","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"2026080709091203700_cit53","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4251\/wjgo.v14.i6.1213","article-title":"Insight on\nBRAFV600E Mutated\nColorectal Cancer Immune Microenvironment","volume":"14","author":"Abushukair","year":"2022","journal-title":"WJGO"},{"issue":"2","key":"2026080709091203700_cit54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.gastro.2013.05.002","article-title":"IDO1Metabolites\nActivate \u03b2-Catenin Signaling to Promote Cancer Cell Proliferation\nand Colon Tumorigenesis in Mice","volume":"145","author":"Thaker","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"2026080709091203700_cit55","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-023-37170-z","article-title":"Quinolinate\nPromotes Macrophage-Induced\nImmune Tolerance in Glioblastoma through the NMDAR\/PPAR\u03b3 Signaling\nAxis","volume":"14","author":"Kesarwani","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"2026080709091203700_cit56","doi-asserted-by":"publisher","first-page":"BSR20221682","DOI":"10.1042\/BSR20221682","article-title":"Tryptophan\nMetabolism and Disposition in Cancer Biology and Immunotherapy","volume":"42","author":"Badawy","year":"2022","journal-title":"Biosci. Rep."},{"issue":"6","key":"2026080709091203700_cit57","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1158\/1535-7163.MCT-17-0603","article-title":"The Unfolded Protein Response: A\nNovel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer","volume":"17","author":"Forsythe","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"2026080709091203700_cit58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00428-016-1961-6","article-title":"Endoplasmic Reticulum\nStress, Unfolded Protein Response and Development of Colon Adenocarcinoma","volume":"469","author":"Piton","year":"2016","journal-title":"Virchows Arch."},{"key":"2026080709091203700_cit59","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/bs.apcsb.2025.10.001","article-title":"Protein Misfolding\nand Its Dual Role\nin Neurodegeneration and Cancer Progression","volume":"148","author":"Jamwal","year":"2025","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"1","key":"2026080709091203700_cit60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12943-025-02472-x","article-title":"Targeting Proteostasis\nfor Cancer Therapy: Current Advances, Challenges, and Future Perspectives","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"2026080709091203700_cit61","doi-asserted-by":"publisher","first-page":"101930","DOI":"10.1016\/j.jbc.2022.101930","article-title":"The Role of Cellular\nProteostasis in Antitumor Immunity","volume":"298","author":"Mercier","year":"2022","journal-title":"J. Biol.\nChem."},{"issue":"4","key":"2026080709091203700_cit62","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-Derived\nCatabolites Are Responsible for\nInhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine\n2,3-Dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"2026080709091203700_cit63","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.2139\/ssrn.3816765","article-title":"Association\nof RAS\/BRAF Status and Prognosis of Metastatic Colorectal Cancer:\nAnalysis of 1002 Consecutive Cases","volume":"29","author":"Tang","year":"2022","journal-title":"Ann. Surg.\nOncol."},{"issue":"5","key":"2026080709091203700_cit64","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/bjc.2011.19","article-title":"BRAF Mutation\nIs a Powerful Prognostic\nFactor in Advanced and Recurrent Colorectal Cancer","volume":"104","author":"Yokota","year":"2011","journal-title":"Br. J. Cancer"},{"key":"2026080709091203700_cit65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2015.04.002","article-title":"Cell Intrinsic and Extrinsic Activators\nof the Unfolded Protein Response in Cancer: Mechanisms and Targets\nfor Therapy","volume":"33","author":"Tameire","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"2026080709091203700_cit66","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","article-title":"The Impact of the\nEndoplasmic Reticulum Protein-Folding\nEnvironment on Cancer Development","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev.\nCancer"},{"issue":"4","key":"2026080709091203700_cit67","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.gendis.2018.09.003","article-title":"A Critical Role of\nthe Thioredoxin Domain Containing Protein 5 (TXNDC5) in Redox Homeostasis\nand Cancer Development","volume":"5","author":"Chawsheen","year":"2018","journal-title":"Genes & Diseases"},{"issue":"8","key":"2026080709091203700_cit68","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/s44319-024-00193-8","article-title":"Recruitment of Ahsa1\nto Hsp90 Is Regulated by a Conserved Peptide That Inhibits ATPase\nStimulation","volume":"25","author":"Hussein","year":"2024","journal-title":"EMBO Rep."},{"issue":"19","key":"2026080709091203700_cit69","doi-asserted-by":"publisher","first-page":"17228","DOI":"10.1074\/jbc.M212761200","article-title":"Aha1 Binds to the Middle Domain of\nHsp90, Contributes to Client Protein Activation, and Stimulates the\nATPase Activity of the Molecular Chaperone","volume":"278","author":"Lotz","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026080709091203700_cit70","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S1097-2765(02)00785-2","article-title":"Activation\nof the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone\nAha1","volume":"10","author":"Panaretou","year":"2002","journal-title":"Mol. Cell"},{"issue":"2","key":"2026080709091203700_cit71","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/ijmm.2018.3664","article-title":"Role of TXNDC5 in Tumorigenesis of Colorectal Cancer\nCells: In Vivo\nand in Vitro Evidence","volume":"42","author":"Tan","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"47","key":"2026080709091203700_cit72","doi-asserted-by":"publisher","first-page":"47079","DOI":"10.1074\/jbc.M308124200","article-title":"a Novel\nProtein-Disulfide Isomerase-like Protein That Is Preferentially Expressed\nin Endothelial Cells Acts as a Stress Survival Factor","volume":"278","author":"Sullivan","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026080709091203700_cit73","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 Chaperone Machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Journal of Proteome Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jproteome.6c00178","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jprobs\/article-pdf\/25\/8\/4132\/65266211\/acs.jproteome.6c00178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jprobs\/article-pdf\/25\/8\/4132\/65266211\/acs.jproteome.6c00178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:17:23Z","timestamp":1786108643000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jprobs\/article\/25\/8\/4132\/5170021\/Tissue-Proteomic-Signatures-of-BRAF-Mutated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,8,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jproteome.6c00178","relation":{},"ISSN":["1535-3893","1535-3907"],"issn-type":[{"value":"1535-3893","type":"print"},{"value":"1535-3907","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}